📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Polichem

1.1 - Company Overview

Polichem Logo

Polichem

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of tools and knowledge to improve the health of patients worldwide.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Polichem

Halia Therapeutics Logo

Halia Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for inflammatory and neurodegenerative disorders, including HT-6184, a novel NEK7/NLRP3 inhibitor in Phase II for lower-risk myelodysplastic syndromes and post-procedure diagnostic biomarkers of inflammation and pain. Pipeline includes NEK7 inhibitors to block NLRP3 inflammasome assembly and LRRK2 inhibitors for diseases such as Parkinson's and Alzheimer's.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Halia Therapeutics company profile →
Altor BioScience Logo

Altor BioScience

HQ: United States Website
  • Description: Provider of immunotherapeutic agents for cancer, viral infections, and autoimmune diseases, including ANKTIVA (N‑803), an IL‑15 receptor agonist for non‑muscle invasive bladder cancer; investigational cancer and viral therapies and vaccines (personalized neoepitope-based, HIV, HPV); Tri‑Ad5 vaccine for Lynch syndrome; STAR Fusion reagents for diagnosis/targeting, STAR Multimer reagents for research; and clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Altor BioScience company profile →
Apotheca Biosciences Logo

Apotheca Biosciences

HQ: United States Website
  • Description: Provider of cutting-edge medical products, nutraceuticals, and formulation and delivery technologies for the healthcare and consumer care industry, including transdermal, sublingual, and nasal delivery technologies for precise, controlled dosing of cannabinoids.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apotheca Biosciences company profile →
KAI Pharmaceuticals Logo

KAI Pharmaceuticals

HQ: United States Website
  • Description: Provider of novel therapeutics through drug discovery and development, with multiple clinical-stage programs in cardiovascular disease, kidney disease, and pain; lead candidate KAI-9803 is in Phase 2b (PROTECTION AMI) evaluating reduction of myocardial injury in heart attack.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full KAI Pharmaceuticals company profile →
Nurix Therapeutics Logo

Nurix Therapeutics

HQ: United States Website
  • Description: Provider of small molecule therapeutics and discovery via the DELigase platform leveraging E3 ligases and DNA-encoded libraries for targeted protein degradation (TPD) and elevation (TPE). Pipeline includes oral candidates NX-5948 (BTK degrader), NX-2127 (BTK/IKZF1/IKZF3 degrader), and NX-1607 (CBL-B inhibitor) for B-cell malignancies, solid tumors, and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nurix Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Polichem

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Polichem

2.2 - Growth funds investing in similar companies to Polichem

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Polichem

4.2 - Public trading comparable groups for Polichem

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Polichem

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Polichem

What does Polichem do?

Polichem is a provider of tools and knowledge to improve the health of patients worldwide.

Who are Polichem's competitors?

Polichem's competitors and similar companies include Halia Therapeutics, Altor BioScience, Apotheca Biosciences, KAI Pharmaceuticals, and Nurix Therapeutics.

Where is Polichem headquartered?

Polichem is headquartered in Switzerland.

How many employees does Polichem have?

Polichem has 1,000 employees 🔒.

When was Polichem founded?

Polichem was founded in 2010 🔒.

What sector and industry vertical is Polichem in?

Polichem is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Polichem

Who are the top strategic acquirers in Polichem's sector and industry

Top strategic M&A buyers and acquirers in Polichem's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Polichem?

Top strategic M&A buyers groups and sectors for Polichem include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Polichem's sector and industry vertical

Which are the top PE firms investing in Polichem's sector and industry vertical?

Top PE firms investing in Polichem's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Polichem's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Polichem's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Polichem's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Polichem include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Polichem's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Polichem?

The key public trading comparables and valuation benchmarks for Polichem include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Polichem for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Polichem with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Polichem's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Polichem with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Polichem's' sector and industry vertical?

Access recent funding rounds and capital raises in Polichem's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Polichem